Evidence map›Paper›PMID 38419091›Full record

ArticleInflammation and regeneration2024

Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer's disease.

Sopak Supakul, Rei Murakami, Chisato Oyama, Tomoko Shindo, Yuki Hatakeyama, Maika Itsuno, Hiroko Bannai, Shinsuke Shibata, Sumihiro Maeda, Hideyuki Okano

Open access · goldAbstract read
In one paragraph

Article in Inflammation and regeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Novel advanced patient-derivedFrontiers in neurology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sopak Supakul *Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0001-5835-2437
Rei Murakami *Department of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Chisato OyamaDepartment of Electrical Engineering and Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, 169-8555, Japan.
Tomoko ShindoElectron Microscope Laboratory, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Yuki HatakeyamaDepartment of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Maika ItsunoDepartment of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Hiroko BannaiDepartment of Electrical Engineering and Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo, 169-8555, Japan.
Shinsuke ShibataElectron Microscope Laboratory, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Sumihiro MaedaDepartment of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan. sumihiro.maeda@keio.jp.
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan. hidokano@a2.keio.jp.ORCID http://orcid.org/0000-0001-7482-5935
Keio University · JPWaseda University · JP

Funding

Cyclic Innovation for Clinical Empowerment JP17pc0101006Grants-in-Aid for Scientific Research (KAKENHI) #21H02450Grants-in-Aid for Scientific Research (KAKENHI) #21J21244Grants-in-Aid for Scientific Research (KAKENHI) #21K06376Grants-in-Aid for Scientific Research (KAKENHI) #22J11065Grants-in-Aid for Scientific Research (KAKENHI) #23K18116Research and Development Grants for Dementia 22dk0207060the Japan Agency for Medical Research and Development (AMED) JP21bm0804003
6 · The paper itself

Abstract

backgroundThe development of induced pluripotent stem cells (iPSCs) technology has enabled human cellular disease modeling for inaccessible cell types, such as neural cells in the brain. However, many of the iPSC-derived disease models established to date typically involve only a single cell type. These monoculture models are inadequate for accurately simulating the brain environment, where multiple cell types interact. The limited cell type diversity in monoculture models hinders the accurate recapitulation of disease phenotypes resulting from interactions between different cell types. Therefore, our goal was to create cell models that include multiple interacting cell types to better recapitulate disease phenotypes.

methodsTo establish a co-culture model of neurons and astrocytes, we individually induced neurons and astrocytes from the same iPSCs using our novel differentiation methods, and then co-cultured them. We evaluated the effects of co-culture on neurons and astrocytes using immunocytochemistry, immuno-electron microscopy, and Ca

resultsThe co-culture of the neurons and astrocytes increased the branching of astrocyte processes, the number of GFAP-positive cells, neuronal activities, the number of synapses, and the density of presynaptic vesicles. In addition, immuno-electron microscopy confirmed the formation of a tripartite synaptic structure in the co-culture model, and inhibition of glutamate transporters increased neuronal activity. Compared to the co-culture model of the control iPSCs, the co-culture model of familial AD developed astrogliosis-like phenotype, which was not observed in the monoculture model of astrocytes.

conclusionsCo-culture of iPSC-derived neurons and astrocytes enhanced the morphological changes mimicking the in vivo condition of both cell types. The formation of the functional tripartite synaptic structures in the co-culture model suggested the mutual interaction between the cells. Furthermore, the co-culture model with the APP

Indexed as

Alzheimer’s diseaseAstrocytesCo-culture modelInduced pluripotent stem cells (iPSCs)NeuronsTripartite synapse

Identifiers

PMID38419091
PMCPMC10900748
OpenAlexW4392238985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.